Ram Devireddy, assistant professor of mechanical engineering at LSU, recently co-authored an article with Todd Monroe, assistant professor of biological and agricultural engineering, investigating the complex effects of nanoparticles on cell freezing. The report was published in the prestigious journal Nanotechnology.
The U.S. Department of Health and Human Services (HHS) today assembled 100 influential leaders from the employer, faith-based, civic and health care communities to participate in a forum to help Americans become more prepared for an influenza pandemic.
Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee did not recommend approval of rimonabant (ZIMULTI(R)) to the US FDA for use in obese and overweight patients with associated risks factors.
A new therapy to re-activate silenced genes in patients who suffer from neurodegenerative diseases or stroke is being developed by researchers at the University of Illinois at Chicago and Cornell University.
Alli is the first and only FDA-approved OTC product for weight loss. It is available in stores June 15. Dr. James Anderson, UK HealthCare weight loss researcher, studied the effects of the drug on mildly to moderately overweight individuals and found it does aid weight loss.
Biovest International, Inc. (OTCBB: BVTI), a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announces a milestone in its effort to gain accelerated conditional approval for BiovaxID?. The independent Data Monitoring Committee (DMC) has requested an interim analysis of all primary and secondary endpoints.
Recognising that Cardiovascular Disease (CVD) kills almost half of the population of Europe and costs the EU ?169 billion annually, the European Heart Health Charter was conceived by the European Society of Cardiology and the European Heart Network with the support of the European Commission and WHO Regional Office for Europe.
The U.S. Food and Drug Administration said that patients who took Acomplia, also known as Zimulti, in clinical trials were more likely to suffer from suicidal thoughts or actions than those on placebo.
Monitoring vegetables while they are growing is crucial in the prevention of contamination of fresh produce with harmful bacteria such as E. coli and Salmonella, say plant pathologists who are members of the American Phytopathological Society.
The U.S. Food and Drug Administration (FDA) has requested that additional data be submitted as part of the complete response to the November 6, 2006 approvable letter for alvimopan in postoperative ileus (POI).